Search

Sunil R Bhonsle

from Oakland, CA
Age ~75
Get Report
Also known as:
Sunll Bhonsle, Sunil Bhonsale, Monsle B Sunil
Phone and address:
6715 Manor Crst, Oakland, CA 94618
(510) 428-0392
Related to:
Veronica A Bhonsle, 65S BhonsleNalini BhonsleSameer S Bhonsle, 43
Connected to:
Hemant K Bhonsle, 32Santosh Bhonsley, 48Kishan Bhoopalam, 37Vamshi K Bhoopalam, 43Vijay A Bhoopalam, 46Ramesh Bhoothapuri, 59Rohit D Bhopatkar, 38Delnaz F Bhopti, 40Madhumita Bhor, 60Taaha N Bhora, 38

Sunil Bhonsle Phones & Addresses

  • 6715 Manor Crst, Oakland, CA 94618 (510) 428-0392
  • Manor Crst, Oakland, CA 94618
  • 311 Oak St #321, Oakland, CA 94607
  • Emeryville, CA
  • Berkeley, CA
  • 6715 Manor Crst, Oakland, CA 94618 (510) 612-0236

Work

Company: Titan pharmaceuticals Position: Chief technology officer

Education

Degree: Associate degree or higher

Emails

s***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Sunil Bhonsle Photo 1

Sunil Bhonsle

View page
Location:
400 Oyster Point Blvd, South San Francisco, CA 94080
Industry:
Pharmaceuticals
Work:
Titan Pharmaceuticals
Chief Technology Officer
Titan Pharmaceuticals
General and Technical
Titan Pharmaceuticals
President
Titan Pharmaceuticals
Chief Operating Officer Executive Vice President

Business Records

Name / Title
Company / Classification
Phones & Addresses
Sunil Bhonsle
President, Director
TITAN PHARMACEUTICALS INC
Mfg Pharmaceutical Preparations · Pharmaceutical Preparations · Pharmaceutical Preparation Manufacturing · Insurance Agencies and Brokerages · Pharmaceutical Research Labora
400 Oyster Pt Blvd STE 505, South San Francisco, CA 94080
(650) 244-4990, (650) 244-4956, (800) 500-6608, (650) 244-0715
Sunil Bhonsle
Treasurer, Secretary
DEVELOPMENTAL THERAPEUTICS, INC
Subdivider/Developer
400 Oyster Pt Blvd STE 505, South San Francisco, CA 94080

Publications

Us Patents

Heterogeneous Implantable Devices For Drug Delivery

View page
US Patent:
20130195950, Aug 1, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/802504
Inventors:
Titan Pharmaceuticals, Inc. - South San Francisco CA, US
Sunil R. Bhonsle - Oakland CA, US
Assignee:
Titan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 9/00
A61K 31/198
US Classification:
424426, 424423, 514567
Abstract:
The present invention comprises compositions, methods and kits for delivering drugs. The invention provides an implantable device for delivery of a pharmaceutical substance to a patient, comprising a core comprising a core polymeric material optionally containing a core pharmaceutical substance, surrounded by a first layer comprising a first-layer pharmaceutical substance and a first-layer polymeric material, optionally surrounded by one or more additional layers comprising an additional pharmaceutical substance and an additional polymeric material, where the core, first, and optional additional polymeric materials may be the same or different, and where the optional core pharmaceutical substance, first-layer pharmaceutical substance, and optional additional pharmaceutical substances are the same or different. Implantation of the device allows a controlled release of drug for an extended period of time. The device may be implanted subcutaneously in an individual in need of continuous treatment with a drug.

Heterogeneous Implantable Devices For Drug Delivery

View page
US Patent:
20130195951, Aug 1, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/802526
Inventors:
Titan Pharmaceuticals, Inc. - South San Francisco CA, US
Sunil R. Bhonsle - Oakland CA, US
Assignee:
Titan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 9/00
A61K 31/485
US Classification:
424426, 424423, 514282
Abstract:
The present invention comprises compositions, methods and kits for delivering drugs. The invention provides an implantable device for delivery of a pharmaceutical substance to a patient, comprising a core comprising a core polymeric material optionally containing a core pharmaceutical substance, surrounded by a first layer comprising a first-layer pharmaceutical substance and a first-layer polymeric material, optionally surrounded by one or more additional layers comprising an additional pharmaceutical substance and an additional polymeric material, where the core, first, and optional additional polymeric materials may be the same or different, and where the optional core pharmaceutical substance, first-layer pharmaceutical substance, and optional additional pharmaceutical substances are the same or different. Implantation of the device allows a controlled release of drug for an extended period of time. The device may be implanted subcutaneously in an individual in need of continuous treatment with a drug.

Heterogeneous Implantable Devices For Drug Delivery

View page
US Patent:
20130202673, Aug 8, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/802539
Inventors:
Titan Pharmaceuticals, Inc. - South San Francisco CA, US
Sunil R. Bhonsle - Oakland CA, US
Assignee:
Titan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 9/00
A61K 45/06
A61K 31/4045
US Classification:
424426, 424423, 514418, 514343
Abstract:
The present invention comprises compositions, methods and kits for delivering drugs. The invention provides an implantable device for delivery of a pharmaceutical substance to a patient, comprising a core comprising a core polymeric material optionally containing a core pharmaceutical substance, surrounded by a first layer comprising a first-layer pharmaceutical substance and a first-layer polymeric material, optionally surrounded by one or more additional layers comprising an additional pharmaceutical substance and an additional polymeric material, where the core, first, and optional additional polymeric materials may be the same or different, and where the optional core pharmaceutical substance, first-layer pharmaceutical substance, and optional additional pharmaceutical substances are the same or different. Implantation of the device allows a controlled release of drug for an extended period of time. The device may be implanted subcutaneously in an individual in need of continuous treatment with a drug.

Heterogeneous Implantable Devices For Drug Delivery

View page
US Patent:
20130189342, Jul 25, 2013
Filed:
Mar 16, 2011
Appl. No.:
13/634535
Inventors:
Rajesh A. Patel - Redwood City CA, US
Sunil R. Bhonsle - Oakland CA, US
Assignee:
TITAN PHARMACEUTICALS, INC. - San Francisco CA
International Classification:
A61K 9/00
A61K 31/485
US Classification:
424426, 424423, 514282, 514423, 514221, 514356, 5142581, 514468, 514301, 514573
Abstract:
The present invention comprises compositions, methods and kits for delivering drugs. The invention provides an implantable device for delivery of a pharmaceutical substance to a patient, comprising a core comprising a core polymeric material optionally containing a core pharmaceutical substance, surrounded by a first layer comprising a first-layer pharmaceutical substance and a first-layer polymeric material, optionally surrounded by one or more additional layers comprising an additional pharmaceutical substance and an additional polymeric material, where the core, first, and optional additional polymeric materials may be the same or different, and where the optional core pharmaceutical substance, first-layer pharmaceutical substance, and optional additional pharmaceutical substances are the same or different. Implantation of the device allows a controlled release of drug for an extended period of time. The device may be implanted subcutaneously in an individual in need of continuous treatment with a drug.

Implantable Devices For Drug Delivery With Reduced Burst Release

View page
US Patent:
20210007973, Jan 14, 2021
Filed:
Oct 5, 2017
Appl. No.:
16/338962
Inventors:
- South San Francisco CA, US
Sunil SREEDHARAN - South San Francisco CA, US
Sunil R. BHONSLE - Oakland CA, US
Assignee:
Titan Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K 9/00
A61K 9/48
A61K 31/197
A61K 31/4045
A61K 31/506
A61K 31/4458
A61K 38/26
A61K 31/485
Abstract:
The invention provides implantable drug delivery devices comprising a core comprising a polymer (or polymer blend) and one or more drugs or pharmaceutical substances, and an outer shell comprising a polymer (or polymer blend) and one or more porogen materials. The invention reduces burst release of drug. Pharmaceuticals such as triiodothyronine (T3) or ropinirole can be delivered by the devices.
Control profile
Sunil R Bhonsle from Oakland, CA, age ~75 Get Report